These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1325427)

  • 61. Detection of transforming growth factor alpha in human urine and plasma.
    Katoh M; Inagaki H; Kurosawa-Ohsawa K; Katsuura M; Tanaka S
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1065-72. PubMed ID: 2157422
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma amino acid patterns in hepatocellular carcinoma.
    Hirayama C; Suyama K; Horie Y; Tanimoto K; Kato S
    Biochem Med Metab Biol; 1987 Oct; 38(2):127-33. PubMed ID: 2823852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-6 Induced Proliferation Is Attenuated by Transforming Growth Factor-β-Induced Signaling in Human Hepatocellular Carcinoma Cells.
    Srivastava A; Sharma H; Khanna S; Sadhu Balasundaram T; Chowdhury S; Chowdhury R; Mukherjee S
    Front Oncol; 2021; 11():811941. PubMed ID: 35127527
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preoperative administration of polysaccharide Kureha and reduced plasma transforming growth factor-β in patients with advanced gastric cancer: A randomized clinical trial.
    Yamashita K; Sakuramoto S; Mieno H; Nemoto M; Shibata T; Katada N; Ohtsuki S; Sakamoto Y; Hoshi K; Wang G; Hemmi O; Satoh T; Kikuchi S; Watanabe M
    Mol Clin Oncol; 2015 May; 3(3):471-478. PubMed ID: 26137253
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biomarkers of gene expression: growth factors and oncoproteins.
    Brandt-Rauf PW
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):807-16. PubMed ID: 9255565
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; Yang ML; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Br J Cancer; 1997; 76(2):244-50. PubMed ID: 9231926
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; Yang ML; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Br J Cancer; 1997; 75(10):1460-6. PubMed ID: 9166938
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of active form of transforming growth factor-beta in cerebrospinal fluid of patients with glioma.
    Tada T; Yabu K; Kobayashi S
    Jpn J Cancer Res; 1993 May; 84(5):544-8. PubMed ID: 8320172
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma.
    Shirai Y; Kawata S; Ito N; Tamura S; Takaishi K; Kiso S; Tsushima H; Matsuzawa Y
    Jpn J Cancer Res; 1992 Jul; 83(7):676-9. PubMed ID: 1325427
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.
    Shirai Y; Kawata S; Tamura S; Ito N; Tsushima H; Takaishi K; Kiso S; Matsuzawa Y
    Cancer; 1994 May; 73(9):2275-9. PubMed ID: 7513247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma.
    Ito N; Kawata S; Tamura S; Shirai Y; Kiso S; Tsushima H; Matsuzawa Y
    Cancer Lett; 1995 Feb; 89(1):45-8. PubMed ID: 7882301
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma.
    Lee D; Chung YH; Kim JA; Lee YS; Lee D; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS
    Oncology; 2012; 82(1):11-8. PubMed ID: 22269311
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesis.
    Divella R; Daniele A; Gadaleta C; Tufaro A; Venneri MT; Paradiso A; Quaranta M
    Anticancer Res; 2012 Jan; 32(1):141-5. PubMed ID: 22213299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Purification and initial characterization of a type beta transforming growth factor from human placenta.
    Frolik CA; Dart LL; Meyers CA; Smith DM; Sporn MB
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3676-80. PubMed ID: 6602340
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
    Assoian RK; Komoriya A; Meyers CA; Miller DM; Sporn MB
    J Biol Chem; 1983 Jun; 258(11):7155-60. PubMed ID: 6602130
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.